Search Results - "Lancar, Remi"
-
1
Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era
Published in AIDS (London) (28-11-2017)“…Non-Hodgkin's lymphoma (NHL) remains among the most frequent malignancies in persons living with HIV (PLWHIV). Survival among patients with HIV-associated…”
Get full text
Journal Article -
2
Phase II Trial of CHOP Plus Rituximab in Patients With HIV-Associated Non-Hodgkin's Lymphoma
Published in Journal of clinical oncology (01-09-2006)“…To evaluate the safety and efficacy of rituximab adjunction to the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen in patients with…”
Get full text
Journal Article -
3
Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial
Published in Annals of internal medicine (03-03-2020)“…Patients diagnosed with advanced HIV infection have a poor prognosis despite initiation of combined antiretroviral therapy (c-ART). To assess the benefit of…”
Get full text
Journal Article -
4
Lymph node prognostic factors in head and neck squamous cell carcinomas
Published in The American journal of surgery (01-11-1994)“…This retrospective study included 914 patients who underwent a lymph node dissection at our institute between 1980 and 1985. The primary tumor sites were oral…”
Get more information
Journal Article -
5
Accurate quantification of CXCR4-using HIV-1 variants by Illumina deep-sequencing
Published in AIDS (London) (23-10-2018)“…Next-generation sequencing is a sensitive method for determining HIV-1 tropism but there is a lack of data on the quantification of X4 variants. We evaluated…”
Get full text
Journal Article -
6
Prospective evaluation of blood Epstein–Barr virus DNA load and antibody profile in HIV-related non-Hodgkin lymphomas
Published in AIDS (London) (01-05-2021)“…The value of Epstein-Barr virus (EBV) biomarkers on the prognosis of HIV-related non-Hodgkin's lymphoma (NHL) has been poorly explored in the combined…”
Get full text
Journal Article -
7
Risk Factors for Seborrhoeic Dermatitis Flares: Case-control and Case-crossover Study
Published in Acta dermato-venereologica (2020)“…Patients with flares of seborrhoeic dermatitis were compared with control outpatients seen during the same time-period in a case-control study, and with…”
Get full text
Journal Article -
8
Development and Validation of an Immunoassay for Identification of Recent Human Immunodeficiency Virus Type 1 Infections and Its Use on Dried Serum Spots
Published in Journal of Clinical Microbiology (01-09-2005)“…The objective was to develop and to validate an immunossay to identify recent human immunodeficiency virus type 1 (HIV-1) infections that can be used on dried…”
Get full text
Journal Article -
9
Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy
Published in PloS one (30-06-2011)“…Progressive multifocal leukoencephalopathy (PML), a rare devastating demyelinating disease caused by the polyomavirus JC (JCV), occurs in severely…”
Get full text
Journal Article -
10
Epstein–Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era
Published in AIDS (London) (01-05-2019)“…OBJECTIVES:Epstein–Barr virus (EBV) has been implicated in lymphomagenesis of HIV-related classical Hodgkin lymphoma (HIV-cHL). The utility of EBV molecular…”
Get full text
Journal Article -
11
Increased Production of B-Cell Activating Cytokines and Altered Peripheral B-Cell Subset Distribution during HIV-Related Classical Hodgkin Lymphoma
Published in Cancers (01-01-2022)“…Classical Hodgkin Lymphoma incidence increases in HIV-1-infected patients (HIV-cHL). HIV infection is associated with higher B-cell activation. Here, in 38…”
Get full text
Journal Article -
12
Alpha interferon administration during structured interruptions of combination antiretroviral therapy in patients with chronic HIV-1 infection: INTERVAC ANRS 105 trial
Published in AIDS (London) (02-01-2011)“…Interferon-α administration during structured treatment interruptions (STIs) was studied in a phase III trial. We randomized 168 chronically infected HIV…”
Get full text
Journal Article -
13
High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort
Published in Clinical infectious diseases (01-11-2015)“…Human immunodeficiency virus (HIV) infection is associated with a high risk of classical Hodgkin's lymphoma (cHL) in the combined antiretroviral therapy (cART)…”
Get full text
Journal Article -
14
Hepatitis C virus or hepatitis B virus coinfection and lymphoma risk in people living with HIV
Published in AIDS (London) (15-03-2020)“…OBJECTIVE:Chronic hepatitis C virus (HCV) and hepatitis B virus (HBV) infections are associated with increased risks of lymphomas in the non-HIV setting. Their…”
Get full text
Journal Article -
15
Immune reconstitution and evolution of B cell stimulating cytokines after R-CHOP therapy for HIV-associated DLBCL
Published in Blood advances (30-09-2024)“…HIV infection is associated with an increased risk of diffuse large B cell lymphoma (DLBCL) that persists despite the advent of combined anti-retroviral…”
Get full text
Journal Article -
16
In situ BCL2 expression is an independent prognostic factor in HIV‐associated DLBCL, a LYMPHOVIR cohort study
Published in British journal of haematology (01-02-2020)“…Summary The prognostic value of cell of origin (COO) classification and BCL2 expression is not well established in diffuse large B‐cell lymphoma (DLBCL)…”
Get full text
Journal Article -
17
Diagnostic value of D-dimer in patients with suspected pulmonary embolism: Results from a multicentre outcome study
Published in Thrombosis research (01-01-2007)“…Abstract Background D-dimer tests are used in various diagnostic strategies to exclude pulmonary embolism (PE). However, their role as an exclusionary…”
Get full text
Journal Article -
18
Coinfection with HCV or HBV Increases the Risk of Lymphoma in HIV-Positive Patients: A Combined Analysis of the Lymphovir-ANRS-CO16 and Fhdh-ANRS-CO4 Cohorts
Published in Blood (08-12-2017)“…Human immunodeficiency virus (HIV) infection has been linked to an increased risk of non-Hodgkin's lymphoma (NHL) and Hodgkin's lymphoma (HL). In the…”
Get full text
Journal Article -
19
Bleeding complications in primary percutaneous coronary intervention of ST-elevation myocardial infarction in a radial center
Published in Catheterization and cardiovascular interventions (01-01-2012)“…Objectives: We evaluated the incidence, types, and prognostic impact of bleeding complications in a non‐selected patient population with ongoing STEMI treated…”
Get full text
Journal Article -
20
High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO 16 LYMPHOVIR Cohort
Published in Clinical infectious diseases (01-11-2015)“…Background. Human immunodeficiency virus (HIV) infection is associated with a high risk of classical Hodgkin's lymphoma (cHL) in the combined antiretroviral…”
Get full text
Journal Article